RxDoctor Payments Data

Krista Celestin, PA

Physician Assistant · Fresno, CANPI 1932599362

Payments from drug & device makers

$2,020in general payments, 2019–2025

Across 100 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$412
  • AstraZeneca$267
  • Lilly USA, LLC$226
  • Novo Nordisk$203
  • Boston Scientific$201
  • Pfizer$116
  • plus $595 from 12 others

What the payments were for

  • Food & beverage$2,020100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,020 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$8,242
Medicare patients
69
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide12$16,612
Rosuvastatin Calcium17$423
Albuterol Sulfate HfaAlbuterol Sulfate13$359
Fluticasone Propionate25$347
Doxycycline Hyclate24$300
Omeprazole12$263
Levocetirizine Dihydrochloride18$249
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$248
Bupropion XlBupropion Hcl13$231
Alprazolam20$217
Baclofen21$207
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst22$201
Amlodipine Besylate18$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$125
Atorvastatin Calcium21$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$203$16,61212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →